首页> 美国卫生研究院文献>Pharmaceuticals >Vasorelaxant Effects Induced by Red Wine and Pomace Extracts of Magliocco Dolce cv.
【2h】

Vasorelaxant Effects Induced by Red Wine and Pomace Extracts of Magliocco Dolce cv.

机译:红酒和Magliocco Dolce cv的果渣提取物诱导的血管舒张作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Several epidemiological studies demonstrate that moderate (red) wine consumption may afford protection against cardiovascular diseases. Protection is ascribed to the biological activity of wine components, many of which, however, are discarded during winemaking. In vitro rat thoracic aorta rings contracted with phenylephrine or KCl were used to assess the vasorelaxant activity of extracts from wine pomaces (seeds and skins) of the Calabrian autochthonous grape variety Magliocco dolce (Arvino). NMR spectroscopy was used to ascertain their chemical composition. Data demonstrate that seed and skin, but not must, extracts are capable of relaxing vascular preparations in an endothelium-dependent manner, similarly to the red wine extract, due to the presence of comparable amounts of bioactive constituents. In rings pre-contracted with 20–30 mM KCl, only seed extracts showed a moderate relaxation. The most efficacious vasodilating extract (wine) showed a good antioxidant profile in both [(2,2-diphenyl-1-picrylhydrazyl)acid] radical (DPPH) and [2,2’-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid)] radical (ABTS) assays. In conclusion, winemaking from Magliocco dolce grape can provide potentially health-promoting by-products useful in cardiovascular disease management.
机译:几项流行病学研究表明,适量(红葡萄酒)饮用可以预防心血管疾病。保护归因于葡萄酒成分的生物活性,但是其中许多在酿酒过程中被丢弃。体外大鼠胸主动脉环与去氧肾上腺素或氯化钾收缩被用于评估卡拉布里亚自发葡萄品种Magliocco dolce(Arvino)的葡萄酒球果(种子和果皮)提取物的血管松弛活性。 NMR光谱用于确定它们的化学组成。数据表明,由于存在相当数量的生物活性成分,与红酒提取物类似,种子和皮肤提取物(但非必须)能够以内皮依赖性方式松弛血管制剂。在预先用20–30 mM KCl收缩的环中,只有种子提取物显示出适度的松弛。最有效的血管舒张提取物(葡萄酒)在[(2,2-二苯基-1-吡啶基肼基)酸]自由基(DPPH)和[2,2'-叠氮基双(3-乙基苯并噻唑啉-6-磺酸]]自由基(ABTS)分析。总之,用Magliocco dolce葡萄酿造葡萄酒可以提供有益健康的副产品,可用于心血管疾病的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号